Read More 4 minute read Pharma Industry News Is Dupixent now the gold standard for asthma with nasal polyps? Inside Sanofi and Regeneron’s big study win Dupixent outperforms Xolair in phase 4 respiratory trial for chronic rhinosinusitis with asthma. Find out what this means for Sanofi and Regeneron’s growth. byPallavi MadhirajuNovember 8, 2025